Репозиторий Университета

Coenzyme Q10 in cardiovascular and metabolic diseases: Current state of the problem

  • Zozina V.
  • Covantev S.
  • Goroshko O.
  • Krasnykh L.
  • Kukes V.
Дата публикации:01.01.2018
Журнал: Current Cardiology Reviews
БД: Scopus
Ссылка: Scopus
Индекс цитирования: 3


© 2018 Bentham Science Publishers. The burden of cardiovascular and metabolic diseases is increasing with every year. Although the management of these conditions has improved greatly over the years, it is still far from perfect. With all of this in mind, there is a need for new methods of prophylaxis and treatment. Coenzyme Q10 (CoQ10) is an essential compound of the human body. There is growing evidence that CoQ10 is tightly linked to cardiometabolic disorders. Its supplementation can be useful in a variety of chronic and acute disorders. This review analyses the role of CoQ10 in hypertension, ischemic heart disease, myocardial infarction, heart failure, viral myocarditis, cardiomyopathies, cardiac toxicity, dyslipidemia, obesity, type 2 diabetes mellitus, metabolic syndrome, cardiac procedures and resuscitation.

Вернуться назад